AYR Wellness Faces Cease Trade Order Amid Filing Delays

Ayr Wellness ( ($TSE:AYR.A) ) has issued an announcement.

AYR Wellness Inc. has announced an update regarding the status of its securities following a delay in filing its interim financial statements for the quarter ending March 31, 2025. As a result of the delay, the Ontario Securities Commission has issued a Failure to File Cease Trade Order, prohibiting trading of the company’s securities in Canada, with limited exceptions. AYR is actively working to resolve the issue and does not anticipate any disruption to its regular operations or its commitment to delivering quality cannabis products.

The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.75 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.

Spark’s Take on TSE:AYR.A Stock

According to Spark, TipRanks’ AI Analyst, TSE:AYR.A is a Neutral.

Ayr Wellness faces significant financial and operational challenges, reflected in its low financial performance score. Weak technical indicators and valuation concerns further weigh on the stock. While strategic initiatives are underway, the delay in financial filings and regulatory issues highlight ongoing uncertainties, resulting in a below-average overall stock score.

To see Spark’s full report on TSE:AYR.A stock, click here.

More about Ayr Wellness

AYR Wellness is a vertically integrated, U.S. multi-state cannabis business operating over 90 licensed dispensaries and offering a range of cannabis consumer packaged goods (CPG) brands. The company is dedicated to providing high-quality cannabis products to its patients and customers while promoting positive impacts within its team and the communities it serves.

Average Trading Volume: 127,791

Technical Sentiment Signal: Sell

Current Market Cap: C$18.1M

For detailed information about AYR.A stock, go to TipRanks’ Stock Analysis page.